{"id":"adjuvant-systemic-therapy","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Adjuvant therapy is given after primary treatment (surgery) to target micrometastatic disease and improve overall survival. The specific mechanism depends on the modality used—chemotherapy, hormone therapy, targeted therapy, or immunotherapy—each working through distinct pathways to prevent cancer recurrence.","oneSentence":"Adjuvant systemic therapy refers to post-operative treatment administered to eliminate residual cancer cells and reduce recurrence risk after surgical resection.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:59:54.547Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Adjuvant treatment of solid tumors post-surgical resection (specific tumor type not specified in available data)"}]},"trialDetails":[{"nctId":"NCT03387553","phase":"EARLY_PHASE1","title":"HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2018-06-06","conditions":"Breast Cancer, Breast Cancer Female, Breast Cancer, Male","enrollment":31},{"nctId":"NCT01272037","phase":"PHASE3","title":"Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2011-02-28","conditions":"Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma, Multicentric Breast Carcinoma","enrollment":5018},{"nctId":"NCT02758951","phase":"PHASE2, PHASE3","title":"Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases","status":"ACTIVE_NOT_RECRUITING","sponsor":"Koen Rovers","startDate":"2017-06-01","conditions":"Colorectal Neoplasm, Colorectal Cancer, Colorectal Neoplasms Malignant","enrollment":358},{"nctId":"NCT02654119","phase":"PHASE2","title":"Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Stage I-II HER2/Neu Positive Breast Cancer After Surgery","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2015-12-11","conditions":"HER2 Positive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7","enrollment":20},{"nctId":"NCT06860542","phase":"PHASE2","title":"Inhaled Budesonide for REcurrence Prevention and Adjuvant THerapy in Checkpoint Inhibitor Pneumonitis","status":"RECRUITING","sponsor":"AHS Cancer Control Alberta","startDate":"2026-02-10","conditions":"Pneumonitis, Immune-related Adverse Event","enrollment":94},{"nctId":"NCT05629585","phase":"PHASE3","title":"A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03)","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2022-11-28","conditions":"Breast Cancer","enrollment":1174},{"nctId":"NCT04042935","phase":"PHASE1","title":"Alpha Lipoic Acid to Decrease Pain and Side Effects in Concurrent Treatment of HNSCC","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2020-02-27","conditions":"HNSCC","enrollment":5},{"nctId":"NCT05660408","phase":"PHASE1, PHASE2","title":"RNA Lipid Particles Targeting Pediatric Recurrent Intracranial Malignancies and Other systEmic Solid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2025-03-12","conditions":"Recurrent Pulmonary Osteosarcoma, Recurrent High-grade Glioma","enrollment":36},{"nctId":"NCT05871099","phase":"PHASE3","title":"Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not","status":"RECRUITING","sponsor":"The Affiliated Hospital of Qingdao University","startDate":"2022-11-20","conditions":"Gastric Cancer","enrollment":616},{"nctId":"NCT07454486","phase":"","title":"TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary Tract Cancer: a Real- World Cohort","status":"NOT_YET_RECRUITING","sponsor":"Aarhus University Hospital","startDate":"2026-03-15","conditions":"Biliary Tract Cancer (BTC), Biliary Tract Cancer (CCA), Gall Bladder Cancer","enrollment":300},{"nctId":"NCT05925218","phase":"","title":"Circulating Tumor DNA Collection From Patients With High Grade Gliomas","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2022-09-02","conditions":"High Grade Glioma","enrollment":70},{"nctId":"NCT07136493","phase":"NA","title":"Circulating Tumor DNA Based Minimal Residual Disease Detection for Patients With Early-Stage Breast Cancer","status":"SUSPENDED","sponsor":"City of Hope Medical Center","startDate":"2026-05-12","conditions":"Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8","enrollment":350},{"nctId":"NCT06632327","phase":"PHASE3","title":"Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer","status":"RECRUITING","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2024-12-11","conditions":"Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8","enrollment":1100},{"nctId":"NCT07053085","phase":"PHASE2","title":"A Study of Surgery and Radiotherapy in People With Breast Cancer","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2025-09-17","conditions":"Metastatic Breast Cancer, HER2-positive Breast Cancer","enrollment":162},{"nctId":"NCT07421141","phase":"PHASE2","title":"De-escalation of Neoadjuvant Treatment (Paclitaxel + HP) in Early HER2+ Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Medical Research Radiological Centre of the Ministry of Health of Russia","startDate":"2023-09-01","conditions":"Breast Cancer, HER2-positive Breast Cancer, Early Breast Cancer","enrollment":186},{"nctId":"NCT04270149","phase":"PHASE1","title":"Cancer Peptides Plus GM-CSF and Adjuvant in Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Herbert Lyerly","startDate":"2020-09-01","conditions":"Breast Cancer","enrollment":8},{"nctId":"NCT07429643","phase":"PHASE2, PHASE3","title":"Endoscopic Ultrasound-Guided Loco-regional Chemotherapy Injection as Adjuvant Therapy for Locally Advanced Pancreatic Cancer.","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-04-15","conditions":"Locally Advanced Pancreatic Cancer","enrollment":20},{"nctId":"NCT04526730","phase":"PHASE2","title":"Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma Patients","status":"COMPLETED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2020-12-22","conditions":"Melanoma","enrollment":17},{"nctId":"NCT06290687","phase":"PHASE2","title":"Partial Cystectomy & Extended Pelvic Lymph Node Dissection With SOC Perioperative Systemic Therapy","status":"RECRUITING","sponsor":"Case Comprehensive Cancer Center","startDate":"2025-02-18","conditions":"Malignant Neoplasm of Bladder, Muscle Invasive Bladder Carcinoma","enrollment":40},{"nctId":"NCT07405307","phase":"","title":"Sarcopenia Risk Screening in Patients With Gastrointestinal Cancer Using SARC-F","status":"RECRUITING","sponsor":"Institute of Oncology Ljubljana","startDate":"2023-09-01","conditions":"Gastrointestinal Cancer, Sarcopenia","enrollment":60},{"nctId":"NCT06384560","phase":"PHASE1, PHASE2","title":"Neoadjuvant Triple Therapy for (Borderline) Resectable Pancreatic Cancer (PREOPANC-5)","status":"RECRUITING","sponsor":"Amsterdam UMC, location VUmc","startDate":"2024-09-23","conditions":"Localized Pancreatic Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Resectable Pancreatic Adenocarcinoma","enrollment":66},{"nctId":"NCT07407920","phase":"PHASE2","title":"Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2025-10-09","conditions":"Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Early Stage HER2-Positive Breast Carcinoma","enrollment":120},{"nctId":"NCT06107920","phase":"PHASE3","title":"Neoadjuvant Chemotherapy for Obstructive Colon cancER First Treated by cOlostomy","status":"RECRUITING","sponsor":"University Hospital, Rouen","startDate":"2024-05-07","conditions":"Colon Cancer","enrollment":232},{"nctId":"NCT07233928","phase":"NA","title":"Breast Cancer Organelle Properties and Protein Expression Atlas in the Three Immunohistochemical Subtypes of Breast Cancers","status":"RECRUITING","sponsor":"Institut Claudius Regaud","startDate":"2026-02-06","conditions":"Early Breast Cancer, Metastatic Breast Cancer","enrollment":1050},{"nctId":"NCT05415215","phase":"PHASE3","title":"A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2022-07-05","conditions":"Early Breast Cancer, Locally Advanced Breast Cancer, Inflammatory Breast Cancer","enrollment":346},{"nctId":"NCT05333874","phase":"EARLY_PHASE1","title":"CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage","status":"ACTIVE_NOT_RECRUITING","sponsor":"Rutgers, The State University of New Jersey","startDate":"2022-04-06","conditions":"Breast Cancer, Early-Onset","enrollment":34},{"nctId":"NCT04700124","phase":"PHASE3","title":"Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-Eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2021-04-21","conditions":"Bladder Cancer","enrollment":808},{"nctId":"NCT01815359","phase":"PHASE2","title":"ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2013-03","conditions":"Appendix Cancer, Colorectal Cancer","enrollment":292},{"nctId":"NCT04990895","phase":"NA","title":"A Research Study to Collect Patient Reported Outcomes Using Electronic Surveys","status":"TERMINATED","sponsor":"AHS Cancer Control Alberta","startDate":"2022-03-30","conditions":"Colorectal Cancer, Breast Cancer","enrollment":8},{"nctId":"NCT07290972","phase":"","title":"Compliance to Cervical Cancer Chemoradiation Guidelines: A Multicentric Implementation Audit and Resource Assessment Initiative of National Cancer Grid of India","status":"RECRUITING","sponsor":"Tata Memorial Hospital","startDate":"2021-02-01","conditions":"Cervical Cancer Screening, Gynecologic Cancers, Treatment Compliance","enrollment":618},{"nctId":"NCT06739655","phase":"NA","title":"Preoperative Radiation Therapy and Immediate Breast Reconstruction","status":"RECRUITING","sponsor":"Cancer Research Antwerp","startDate":"2025-02-20","conditions":"Breast Neoplasms, Breast Carcinoma, Breast Adenocarcinoma","enrollment":180},{"nctId":"NCT06833502","phase":"PHASE2","title":"Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer","status":"RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2025-02-24","conditions":"Breast Cancer, Node-positive Breast Cancer","enrollment":120},{"nctId":"NCT05129969","phase":"","title":"Registry Platform Ovarian and Endometrial Cancer","status":"RECRUITING","sponsor":"iOMEDICO AG","startDate":"2021-11-25","conditions":"Ovarian Cancer, Endometrial Cancer, Ovary Neoplasm","enrollment":1975},{"nctId":"NCT07266025","phase":"PHASE2","title":"Adebrelimab Combined With Induction Chemotherapy or SHR-8068 for Mismatch Repair-Deficient/Microsatellite Instability-High (dMMR/MSI-H) Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma：A Randomized, Non-comparative Phase 2 Study","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2026-01-30","conditions":"Gastric Adenocarcinoma, Gastroesophageal Adenocarcinoma, Mismatch Repair Deficient or MSI-High Solid Tumors","enrollment":30},{"nctId":"NCT06481813","phase":"NA","title":"Prospective, Longitudinal Biocollection in Thoracic Oncology, Including Newly Diagnosed Lung Cancer Patients","status":"RECRUITING","sponsor":"Nantes University Hospital","startDate":"2024-12-10","conditions":"Lung Cancer, Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma","enrollment":730},{"nctId":"NCT07335770","phase":"","title":"Cardiac Magnetic Resonance for Diagnosis, Treatment Guidance and Prognosis of Cardiac Masses (CMR)","status":"ENROLLING_BY_INVITATION","sponsor":"Minjie Lu","startDate":"2008-01-01","conditions":"Cardiac Masses","enrollment":2000},{"nctId":"NCT06155279","phase":"PHASE2","title":"Induction Chemo+Immunotherapy in Resectable Epithelioid and Biphasic Pleural Mesothelioma (CHIMERA Study)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Istituto Oncologico Veneto IRCCS","startDate":"2024-11-06","conditions":"Pleural Mesothelioma","enrollment":41},{"nctId":"NCT06210776","phase":"","title":"A Study to Assess the Effectiveness of Trastuzumab Deruxtecan in Chinese Breast Cancer Patients (REFRESH)","status":"RECRUITING","sponsor":"Daiichi Sankyo","startDate":"2024-01-15","conditions":"HER2-positive Breast Cancer, HER2-low Breast Cancer, Breast Cancer","enrollment":800},{"nctId":"NCT06295159","phase":"PHASE2","title":"Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma","status":"RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2024-05-17","conditions":"Melanoma Stage III, Melanoma Stage IV, Advanced Melanoma","enrollment":90},{"nctId":"NCT02511106","phase":"PHASE3","title":"AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy.","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2015-10-21","conditions":"Stage IB-IIIA Non-small Cell Lung Carcinoma","enrollment":682},{"nctId":"NCT05380713","phase":"PHASE2","title":"......SMARTEST Trial......","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2022-05-03","conditions":"Mesothelioma, Malignant","enrollment":30},{"nctId":"NCT07304258","phase":"PHASE2","title":"A Prospective, Phase II Clinical Study of HIPEC Combined With NIPS and Tislelizumab Conversion Therapy for Gastric Cancer With Peritoneal Metastasis With Positive Cytology Alone or PCI Score ≤10","status":"NOT_YET_RECRUITING","sponsor":"Hebei Medical University","startDate":"2025-12-12","conditions":"Gastric Cancer Peritoneal Metastases","enrollment":30},{"nctId":"NCT04711824","phase":"PHASE1, PHASE2","title":"Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases","status":"RECRUITING","sponsor":"Colette Shen","startDate":"2022-03-09","conditions":"Breast Cancer, Brain Metastases, Adult","enrollment":41},{"nctId":"NCT03433898","phase":"EARLY_PHASE1","title":"This Study Aims to Find a Safe and Effective Dose of BI 754091. The Study Also Aims to Find Safe and Effective Doses of BI 754091 and BI 754111 in Combination. This Study is Done in Asian Patients With Different Types of Cancer","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2018-02-23","conditions":"Neoplasms","enrollment":146},{"nctId":"NCT05860296","phase":"PHASE1, PHASE2","title":"Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers","status":"TERMINATED","sponsor":"SignalChem Lifesciences Corporation","startDate":"2023-05-31","conditions":"Lung Cancer, Nonsmall Cell, Lung Cancer Stage IV, Lung Cancer Metastatic","enrollment":36},{"nctId":"NCT07241793","phase":"PHASE2","title":"Phase II Study of Trastuzumab Rezetecan or in Combination With Adebrelimab in HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC)","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2025-11-20","conditions":"Urothelial Carcinoma, Advanced Urothelial Carcinoma, Urothelial Carcinoma Recurrent","enrollment":96},{"nctId":"NCT07285434","phase":"EARLY_PHASE1","title":"Clinical Study of the Therapeutic Effectiveness of In-silico-Designed, Machine Learning Inspired, and Quantum-molecularly Coupled Personalized Neoantigenic Vaccines Microlyvaq™ in Patients With Advanced Non-small Cell Lung Cancer","status":"ENROLLING_BY_INVITATION","sponsor":"Biogenea Pharmaceuticals Ltd.","startDate":"2026-02-02","conditions":"NSCLC (Non-small Cell Lung Cancer), Squamous Lung Cancer With FGFR1 Amplification, Non-Squamous Non Small Cell Lung Cancer","enrollment":90},{"nctId":"NCT07262138","phase":"","title":"Active Surveillance in Older Women With ER+ Breast Cancer","status":"RECRUITING","sponsor":"University of Pittsburgh","startDate":"2025-11-01","conditions":"Early Stage Estrogen Receptor (ER) Positive Breast Cancer","enrollment":50},{"nctId":"NCT00353483","phase":"","title":"Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2005-09-14","conditions":"Breast Neoplasms","enrollment":300},{"nctId":"NCT06931769","phase":"","title":"TAO-Towards Optimal (Neo)Adjuvant Systemic Therapy of Stage III Triple-negative Breast Cancer","status":"RECRUITING","sponsor":"The Netherlands Cancer Institute","startDate":"2025-11-06","conditions":"Breast Cancer","enrollment":100},{"nctId":"NCT04727242","phase":"PHASE2","title":"CytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine Leiomyosarcoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Stanford University","startDate":"2021-01-28","conditions":"LMS - Leiomyosarcoma, Uterine Leiomyosarcoma","enrollment":17},{"nctId":"NCT05088395","phase":"NA","title":"Analysis of Circulating Tumor mArkers in Blood 4 - ALCINA 4","status":"RECRUITING","sponsor":"Institut Curie","startDate":"2022-05-19","conditions":"Cancer","enrollment":2050},{"nctId":"NCT04733118","phase":"PHASE2","title":"Chemotherapy-Free pCR-Guided Strategy With Trastuzumab-pertuzumab and T-DM1 in HER2-positive Early Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"MedSIR","startDate":"2021-08-05","conditions":"Early Breast Cancer","enrollment":393},{"nctId":"NCT04363801","phase":"PHASE2","title":"A Study of DKN-01 in Combination With Tislelizumab ± Chemotherapy in Patients With Gastric or Gastroesophageal Cancer","status":"TERMINATED","sponsor":"Leap Therapeutics, Inc.","startDate":"2020-07-29","conditions":"Gastric Cancer, Gastric Adenocarcinoma, GastroEsophageal Cancer","enrollment":247},{"nctId":"NCT07058805","phase":"PHASE2","title":"Compartmentalized Postoperative Radiotherapy in Head and Neck Cancer","status":"NOT_YET_RECRUITING","sponsor":"Olgun Elicin","startDate":"2026-01-01","conditions":"Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma","enrollment":50},{"nctId":"NCT07090174","phase":"PHASE2","title":"Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV","status":"NOT_YET_RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2025-10-20","conditions":"HPV Associated Cancers, HIV (Human Immunodeficiency Virus), Anal Cancer","enrollment":27},{"nctId":"NCT04722523","phase":"PHASE1","title":"A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2021-01-20","conditions":"Head and Neck Cancer, Head Cancer, Head Cancer Neck","enrollment":40},{"nctId":"NCT05839912","phase":"NA","title":"Excision of Lymph Node Trial (EXCILYNT) (Mel69)","status":"RECRUITING","sponsor":"Craig L Slingluff, Jr","startDate":"2023-09-06","conditions":"Melanoma","enrollment":66},{"nctId":"NCT06133543","phase":"NA","title":"Robot-assisted ICG-guided Sentinel Node Biopsy in Testicular Cancer","status":"RECRUITING","sponsor":"Heinrich-Heine University, Duesseldorf","startDate":"2023-09-06","conditions":"Germ Cell Tumor, Seminoma, Nonseminomatous Germ Cell Tumor","enrollment":44},{"nctId":"NCT07010939","phase":"","title":"A Study of Treatment-Related Toxicities and Quality of Life After Local Therapy in Chinese Breast Cancer Patients","status":"RECRUITING","sponsor":"FangYi","startDate":"2025-04-07","conditions":"Breast Neoplasms, Quality of Life (QOL), Toxicities","enrollment":3000},{"nctId":"NCT07007182","phase":"PHASE2","title":"Conversion Therapy Plus Surgery and Radiotherapy for Retroperitoneal Nodal Metastases in Gastric Cancer","status":"NOT_YET_RECRUITING","sponsor":"Jinbo Yue","startDate":"2025-10-01","conditions":"Gastric Adenocarcinoma, Stomach Neoplasms","enrollment":54},{"nctId":"NCT05417737","phase":"","title":"Patients Referred to the Chronic Pain Unit for Palliative Treatment With Ozone Therapy Between 2022 and 2025","status":"RECRUITING","sponsor":"Bernardino Clavo, MD, PhD","startDate":"2022-06-15","conditions":"Radiation Toxicity, Chemotherapeutic Toxicity, Chemotherapy-induced Peripheral Neuropathy","enrollment":105},{"nctId":"NCT00766142","phase":"PHASE2","title":"Chemotherapy and Cetuximab in Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal Cancer","status":"TERMINATED","sponsor":"Institut Bergonié","startDate":"2007-05-01","conditions":"Colorectal Cancer, Primary Peritoneal Cavity Cancer","enrollment":18},{"nctId":"NCT07133490","phase":"PHASE2","title":"INTERACT Stomach-II","status":"NOT_YET_RECRUITING","sponsor":"Erasmus Medical Center","startDate":"2025-10-01","conditions":"Peritoneal Metastases From Gastric Cancer","enrollment":49},{"nctId":"NCT05705401","phase":"PHASE3","title":"Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer","status":"RECRUITING","sponsor":"NRG Oncology","startDate":"2023-03-13","conditions":"HER2-positive Breast Cancer","enrollment":1300},{"nctId":"NCT06839092","phase":"PHASE3","title":"Prophylactic PIPAC in Patients With High-risk Colorectal Cancer","status":"NOT_YET_RECRUITING","sponsor":"Jeremy Meyer","startDate":"2026-01","conditions":"Colorectal Cancer Control and Prevention, Colorectal Cancer, Colorectal Cancer Stage II","enrollment":160},{"nctId":"NCT05608564","phase":"NA","title":"Local and Systemic Antimicrobials in Non-surgical Periodontal Therapy","status":"COMPLETED","sponsor":"University of Belgrade","startDate":"2023-01-17","conditions":"Periodontitis","enrollment":38},{"nctId":"NCT03348150","phase":"PHASE3","title":"Gastrectomy + Cytoreductive Surgery + HIPEC for Gastric Cancer With Peritoneal Dissemination.","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Netherlands Cancer Institute","startDate":"2017-10-01","conditions":"Stomach Neoplasm, Peritoneal Carcinomatosis","enrollment":102},{"nctId":"NCT06427252","phase":"PHASE2","title":"The Efficacy and Safety of HIPEC Combined With PD-1 and SOX Chemotherapy for the Translational Treatment of GC or EGJC With PM","status":"ACTIVE_NOT_RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2024-05-31","conditions":"Gastric Cancer, Metastatic","enrollment":50},{"nctId":"NCT06248528","phase":"NA","title":"Comparing the Prognosis of Patients With HCC and PVTT Treated With Surgery Versus Locoregional Therapy.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Chen Xiaoping","startDate":"2019-12-01","conditions":"Hepatocellular Carcinoma","enrollment":1076},{"nctId":"NCT06914440","phase":"PHASE2","title":"Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer","status":"RECRUITING","sponsor":"Xijing Hospital","startDate":"2025-06-05","conditions":"Breast Cancer","enrollment":27},{"nctId":"NCT06990737","phase":"PHASE2","title":"Phase 2 Pragmatic Trial of Sentinel Lymph Node Biopsy (SLNB) in Patients With Clinically Node-Negative (cN0), High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) of the Head and Neck","status":"RECRUITING","sponsor":"University of California, Davis","startDate":"2025-06-25","conditions":"Cutaneous Squamous Cell Carcinoma of the Head and Neck, Clinically Node-Negative (cN0), High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) of the Head and Neck","enrollment":24},{"nctId":"NCT02990611","phase":"","title":"Observational Study of Nivolumab Monotherapy or in Combination With Ipilimumab in Participants With Advanced Melanoma and in Participants With Adjuvant Nivolumab Therapy","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2016-12-06","conditions":"Melanoma","enrollment":1087},{"nctId":"NCT06115681","phase":"","title":"Real-world Study of Dedifferentiated Liposarcoma Patients in China","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2024-03-13","conditions":"Dedifferentiated Liposarcoma","enrollment":1390},{"nctId":"NCT06719362","phase":"PHASE1","title":"A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies","status":"RECRUITING","sponsor":"Providence Health & Services","startDate":"2025-06-17","conditions":"Advanced Solid Tumors","enrollment":110},{"nctId":"NCT01564056","phase":"PHASE3","title":"Adjuvant Systemic Treatment for (ER)-Positive HER2-negative Breast Carcinoma in Women Over 70 According to Genomic Grade (GG): Chemotherapy + Endocrine Treatment Versus Endocrine Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"UNICANCER","startDate":"2012-04-12","conditions":"Breast Cancer","enrollment":1989},{"nctId":"NCT03645928","phase":"PHASE2","title":"Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors","status":"RECRUITING","sponsor":"Iovance Biotherapeutics, Inc.","startDate":"2019-05-07","conditions":"Metastatic Melanoma, Squamous Cell Carcinoma of the Head and Neck, Non-small Cell Lung Cancer","enrollment":245},{"nctId":"NCT04830124","phase":"PHASE2","title":"Nemvaleukin Alfa Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cutaneous or Mucosal Melanoma - ARTISTRY-6","status":"TERMINATED","sponsor":"Mural Oncology, Inc","startDate":"2021-09-27","conditions":"Cutaneous Melanoma, Mucosal Melanoma","enrollment":173},{"nctId":"NCT06991491","phase":"PHASE2","title":"Ivonescimab With GnP and SBRT in Patients With Metastatic Pancreatic Cancer (WGOG-PAN 004)","status":"NOT_YET_RECRUITING","sponsor":"West China Hospital","startDate":"2025-06-01","conditions":"Pancreatic Cancer","enrollment":29},{"nctId":"NCT06979661","phase":"EARLY_PHASE1","title":"Trial of ctDNA of Guidance to Determine PostOperative Radiation Therapy","status":"NOT_YET_RECRUITING","sponsor":"Rutgers, The State University of New Jersey","startDate":"2025-06-01","conditions":"Lung Cancer, Non Small Cell Lung Cancer, Lung Cancer Recurrent","enrollment":25},{"nctId":"NCT02998385","phase":"PHASE3","title":"Chemo-radiotherapy Versus Radiotherapy in the Treatment of Salivary Glands and Nasal Tumors (IMRT or Protontherapy)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Groupe Oncologie Radiotherapie Tete et Cou","startDate":"2017-01-20","conditions":"HNSCC","enrollment":342},{"nctId":"NCT02917421","phase":"PHASE1, PHASE2","title":"Accelerated Radiation Therapy (ART) to the Breast and Nodal Stations","status":"ACTIVE_NOT_RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2016-12-19","conditions":"Breast Cancer","enrollment":88},{"nctId":"NCT06946901","phase":"PHASE2","title":"The Safety and Effectiveness of Hyperthermic Intraperitoneal Chemotherapy Combined With Intravenous Chemotherapy for Peritoneal Metastatic Pancreatic Cancer, a Phase II Clinical Trial","status":"RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2025-04-03","conditions":"Hyperthermic Intraperitoneal Chemotherapy, Peritoneal Metastatic Pancreatic Cancer","enrollment":90},{"nctId":"NCT03475121","phase":"PHASE3","title":"Treatment Protocol for Non-Metastatic Unilateral Retinoblastoma","status":"COMPLETED","sponsor":"Hospital JP Garrahan","startDate":"2018-01-01","conditions":"Unilateral Retinoblastoma","enrollment":84},{"nctId":"NCT06685887","phase":"PHASE2","title":"A Clinical Study Evaluating the Efficacy of Systemic Chemotherapy and Immune Checkpoint Inhibitors Combined With Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer Patients With Peritoneal Metastasis","status":"RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2025-02-15","conditions":"Gastric Cancer","enrollment":34},{"nctId":"NCT05900908","phase":"PHASE4","title":"Post-operative Adjuvant Therapy w/wo GammaTile + Systemic Therapy","status":"WITHDRAWN","sponsor":"GT Medical Technologies, Inc.","startDate":"2025-05","conditions":"Glioblastoma","enrollment":""},{"nctId":"NCT04474964","phase":"NA","title":"Focal Radiotherapy Plus Low Dose Craniospinal Irradiation Followed by Adjuvant Chemotherapy in WNT Medulloblastoma.","status":"RECRUITING","sponsor":"Tata Memorial Centre","startDate":"2020-08-13","conditions":"Medulloblastoma, WNT-activated","enrollment":30},{"nctId":"NCT04517214","phase":"PHASE2","title":"Comparing Chemotherapy With/Without Toripalimab For Primary Metastatic Nasopharyngeal Carcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fudan University","startDate":"2020-11-01","conditions":"Nasopharyngeal Carcinoma","enrollment":100},{"nctId":"NCT00059930","phase":"PHASE1","title":"Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2003-01","conditions":"Colorectal Cancer, Metastatic Cancer","enrollment":38},{"nctId":"NCT06306612","phase":"NA","title":"CytoREductive prostAtectomy for Poly-metastatic Hormone sensiTIVE Prostate Cancer","status":"RECRUITING","sponsor":"RenJi Hospital","startDate":"2024-03-21","conditions":"Prostate Cancer","enrollment":192},{"nctId":"NCT04022616","phase":"","title":"Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients","status":"RECRUITING","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2010-06-04","conditions":"Breast Cancer","enrollment":99},{"nctId":"NCT06660446","phase":"NA","title":"Exercise During Chemotherapy Treatment As Adjuvant Program in Patients with Lymphoma: EDONOLA Study.","status":"RECRUITING","sponsor":"Biogipuzkoa Health Research Institute","startDate":"2024-10-08","conditions":"Lymphoma","enrollment":180},{"nctId":"NCT06570863","phase":"NA","title":"To Evaluate the Effects of Systemic Probiotics & Antibiotics and Local Application of Antibiotics As an Adjuvant to NSPT","status":"COMPLETED","sponsor":"Dr fizza khalid","startDate":"2022-07-01","conditions":"Periodontitis, Adult","enrollment":120},{"nctId":"NCT04158141","phase":"PHASE3","title":"Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma","status":"TERMINATED","sponsor":"NRG Oncology","startDate":"2020-01-29","conditions":"Pleural Biphasic Mesothelioma, Pleural Epithelioid Mesothelioma, Stage I Pleural Malignant Mesothelioma AJCC v8","enrollment":16},{"nctId":"NCT06352567","phase":"","title":"Symptoms Associated with Chemotherapy-Induced Peripheral Neuropathy","status":"COMPLETED","sponsor":"Izmir Bakircay University","startDate":"2024-01-18","conditions":"Chemotherapy-induced Peripheral Neuropathy, Breast Cancer, Breast Cancer Female","enrollment":74},{"nctId":"NCT06449781","phase":"PHASE2","title":"177Lu-PSMA as a Systemic Adjuvant Treatment in Patients With High and Very High Risk Prostate Cancer","status":"RECRUITING","sponsor":"Maria Sklodowska-Curie National Research Institute of Oncology","startDate":"2025-01-09","conditions":"Prostate Cancer","enrollment":200},{"nctId":"NCT06769919","phase":"PHASE2, PHASE3","title":"A Randomized Controlled Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined with Systemic Therapy for Early-stage Breast Cancer","status":"NOT_YET_RECRUITING","sponsor":"Xijing Hospital","startDate":"2024-12-31","conditions":"Breast Cancer","enrollment":340},{"nctId":"NCT06762782","phase":"PHASE2","title":"Clinical Study on the Effectiveness and Safety of Lenvatinib As Adjuvant Treatment for Patients with High-risk Recurrence of Hepatocellular Carcinoma After Surgery","status":"RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2025-02","conditions":"Hepatocellular Carcinoma (HCC), Adjuvant Therapy in Patients with Hepatocellular Carcinoma (HCC) At High Risk of Recurrence After Curative Resection or Ablation","enrollment":276},{"nctId":"NCT05607030","phase":"PHASE2","title":"A Second Trial of the Abbreviated Protocol Two-Stage Exchange","status":"COMPLETED","sponsor":"Osteal Therapeutics, Inc.","startDate":"2023-01-23","conditions":"Prosthetic-joint Infection","enrollment":76},{"nctId":"NCT04843865","phase":"NA","title":"TCM as an Adjuvant Treatment in Breast Cancer Patients","status":"RECRUITING","sponsor":"Universiti Tunku Abdul Rahman","startDate":"2022-04-22","conditions":"Breast Cancer, Musculoskeletal Pain","enrollment":30}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1422,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Trastuzumab","T-DM1","Trastuzumab Emtansine","chemotherapy or hormone therapy"],"phase":"phase_3","status":"active","brandName":"Adjuvant Systemic Therapy","genericName":"Adjuvant Systemic Therapy","companyName":"National Medical Research Radiological Centre of the Ministry of Health of Russia","companyId":"national-medical-research-radiological-centre-of-the-ministry-of-health-of-russi","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Adjuvant systemic therapy refers to post-operative treatment administered to eliminate residual cancer cells and reduce recurrence risk after surgical resection. Used for Adjuvant treatment of solid tumors post-surgical resection (specific tumor type not specified in available data).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}